Dingding Liu
Dingding Liu has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Ao Li
Ministry of Education Key Laboratory of Model Animal for Disease Study, Department of Otolaryngology Head and Neck Surgery, Jiangsu Provincial Key Medical Discipline (Laboratory), the Affiliated Drum Tower Hospital of Medical School and the Model Animal Research Center of Medical School, Nanjing University, Nanjing 210008, China
1 shared publication Dengbin Ma
Department of Otolaryngology Head and Neck Surgery, Jiangsu Provincial Key Medical Discipline (Laboratory), Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
1 shared publication- Fan Wang
School of Minerals Processing and Bioengineering, Central South University, Changsha 410083, China
1 shared publication - Guoqiang Wan
Ministry of Education Key Laboratory of Model Animal for Disease Study, Department of Otolaryngology Head and Neck Surgery, Jiangsu Provincial Key Medical Discipline (Laboratory), the Affiliated Drum Tower Hospital of Medical School and the Model Animal Research Center of Medical School, Nanjing University, Nanjing 210008, China
1 shared publication Han Zhou
Department of Otolaryngology Head and Neck Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Jiangsu Provincial Medical Key Discipline (Laboratory), Nanjing, China
1 shared publicationHanqi Fan
Department of Otolaryngology Head and Neck Surgery, Jiangsu Provincial Key Medical Discipline (Laboratory), Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
1 shared publication
Latest Publications
- Open Access
- 12 August 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (33)
Blood–labyrinth barrier damage mediated by granzymes from cytotoxic lymphocytes results in hearing loss in systemic lupus erythematosus
Hearing loss (HL) in patients with systemic lupus erythematosus (SLE) has been widely reported, though the underlying mechanisms remain unclear. In this study, we demonstrate significant HL in an imiquimod-induced mouse model of SLE, accompanied by blood–labyrinth barrier (BLB) damage in the stria vascularis (SV). We found that cytotoxic CD8 + T lymphocytes and natural killer cells mediate BLB disruption, with granzyme b (Gzmb) acting as the primary factor inducing cell death of the cochlear capillary endothelial cells. Remarkably, inhibiting Gzmb by Serpinb9 significantly alleviates the elevations of hearing thresholds in imiquimod-induced SLE model mice, suggesting a therapeutic target for autoimmune-related HL. Our findings provide insights into the pathogenesis of SLE-related HL and propose Gzmb inhibition as a potential therapeutic strategy.
- 12 August 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (33)
Open AccessBlood–labyrinth barrier damage mediated by granzymes from cytotoxic lymphocytes results in hearing loss in systemic lupus erythematosus
Hearing loss (HL) in patients with systemic lupus erythematosus (SLE) has been widely reported, though the underlying mechanisms remain unclear. In this study, we demonstrate significant HL in an imiquimod-induced mouse model of SLE, accompanied by blood–labyrinth barrier (BLB) damage in the stria vascularis (SV). We found that cytotoxic CD8 + T lymphocytes and natural killer cells mediate BLB disruption, with granzyme b (Gzmb) acting as the primary factor inducing cell death of the cochlear capillary endothelial cells. Remarkably, inhibiting Gzmb by Serpinb9 significantly alleviates the elevations of hearing thresholds in imiquimod-induced SLE model mice, suggesting a therapeutic target for autoimmune-related HL. Our findings provide insights into the pathogenesis of SLE-related HL and propose Gzmb inhibition as a potential therapeutic strategy.
- Open Access
- 31 July 2023
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 104 (10) , 638-644
Primary Surgical Management of Laryngeal Neuroendocrine Neoplasms: A Single Institution Case Series
Objective: Laryngeal neuroendocrine neoplasms (NENs) are rare diseases. A single institution retrospective study was done of the outcome of patients with laryngeal NENs who undergo primary surgery as the first treatment modality. Methods: Retrospective analysis of medical records of patients with laryngeal NENs between 2009 and 2018. Cases were classified by applying the 2022 World Health organization Classification of Head and Neck Tumors (5th edition). Results: Six patients were eligible at our tertiary center: 1 large cell neuroendocrine carcinoma (NEC), 3 small cell NEC, 1 neuroendocrine tumor grade 1, and 1 neuroendocrine tumor grade 2. All admitted patients received upfront surgeries, including 3 transoral CO 2 laser surgeries and 3 total laryngectomies with or without elective neck dissection. Four patients underwent subsequent chemoradiotherapy. Although 3 patients had recurrent disease and distal metastasis, the overall survival was generally improved. Conclusion: According to our institutional experience, upfront surgery in the first-line setting of a multi-modality approach with adjuvant chemoradiotherapy plays a very important role in managing laryngeal NECs, and may confer additional survival benefit in some patients of the large cell carcinoma subgroup.
- 31 July 2023
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 104 (10) , 638-644
Open AccessPrimary Surgical Management of Laryngeal Neuroendocrine Neoplasms: A Single Institution Case Series
Objective: Laryngeal neuroendocrine neoplasms (NENs) are rare diseases. A single institution retrospective study was done of the outcome of patients with laryngeal NENs who undergo primary surgery as the first treatment modality. Methods: Retrospective analysis of medical records of patients with laryngeal NENs between 2009 and 2018. Cases were classified by applying the 2022 World Health organization Classification of Head and Neck Tumors (5th edition). Results: Six patients were eligible at our tertiary center: 1 large cell neuroendocrine carcinoma (NEC), 3 small cell NEC, 1 neuroendocrine tumor grade 1, and 1 neuroendocrine tumor grade 2. All admitted patients received upfront surgeries, including 3 transoral CO 2 laser surgeries and 3 total laryngectomies with or without elective neck dissection. Four patients underwent subsequent chemoradiotherapy. Although 3 patients had recurrent disease and distal metastasis, the overall survival was generally improved. Conclusion: According to our institutional experience, upfront surgery in the first-line setting of a multi-modality approach with adjuvant chemoradiotherapy plays a very important role in managing laryngeal NECs, and may confer additional survival benefit in some patients of the large cell carcinoma subgroup.
- 28 July 2016
- Published by SAGE Publications in Advances in Structural Engineering
- Vol. 19 (10) , 1650-1660
Joint strength reduction factor of internally ring-stiffened tubular joints at elevated temperatures
This article presents the results of a numerical parametric study on the ultimate strength of internally crown- and saddle-stiffened circular hollow section tubular DT-, T-, and Y-joints subjected to brace axial compression or tension at elevated temperatures. Using well-validated finite element models, an extensive study of 640 ring-stiffened tubular joints consisting of 36 DT-joints, 36 T-joints, and 8 Y-joints at different temperatures ranging from 20°C to 800°C was conducted. The strength of the stiffened joints was obtained from finite element analysis. The joint strength reduction was compared with the reduction factors of steel yield stress and elastic modulus at elevated temperatures. The parametric study shows that the effects of joint geometric parameters and stiffening position on the strength reduction of the stiffened DT-, T-, and Y-joints at elevated temperatures fall in a narrow range. An equation for predicting the strength reduction of the stiffened DT-, T-, and Y-joints at elevated temperatures was proposed by introducing a temperature factor. The statistical analysis shows that the proposed equation could provide reasonably accurate joint strength predictions.
- 28 July 2016
- Published by SAGE Publications in Advances in Structural Engineering
- Vol. 19 (10) , 1650-1660
Joint strength reduction factor of internally ring-stiffened tubular joints at elevated temperatures
This article presents the results of a numerical parametric study on the ultimate strength of internally crown- and saddle-stiffened circular hollow section tubular DT-, T-, and Y-joints subjected to brace axial compression or tension at elevated temperatures. Using well-validated finite element models, an extensive study of 640 ring-stiffened tubular joints consisting of 36 DT-joints, 36 T-joints, and 8 Y-joints at different temperatures ranging from 20°C to 800°C was conducted. The strength of the stiffened joints was obtained from finite element analysis. The joint strength reduction was compared with the reduction factors of steel yield stress and elastic modulus at elevated temperatures. The parametric study shows that the effects of joint geometric parameters and stiffening position on the strength reduction of the stiffened DT-, T-, and Y-joints at elevated temperatures fall in a narrow range. An equation for predicting the strength reduction of the stiffened DT-, T-, and Y-joints at elevated temperatures was proposed by introducing a temperature factor. The statistical analysis shows that the proposed equation could provide reasonably accurate joint strength predictions.